Concentrix Corporation (CNXC) Stock Price & How to Invest

Concentrix Corporation runs customer support, sales, trust-and-safety and back-office operations for large companies, staffing contact centers in dozens of countries and increasingly layering software and AI agents on top through its iX Suite. It was spun out of SYNNEX in December 2020 and roughly doubled in size by buying Webhelp in 2023. Revenue is close to $10 billion a year, spread across technology, retail and travel, banking and insurance, healthcare and other verticals, with long-tenured top clients (the company cites 16+ years average tenure for its top 25).

The investment picture is a tug of war. On one side, Concentrix keeps throwing off cash (record Q3 adjusted free cash flow of ~$218M, full-year guidance of ~$630M to $650M), non-GAAP margins are inching up, and the stock sits at roughly 2.4x non-GAAP earnings with a raised dividend. On the other, revenue is shrinking slightly, two hyperscaler clients are cutting support volumes into early 2027, and the market cap has fallen far enough that Concentrix wrote down ~$1.05B of goodwill in Q3, producing a large GAAP loss. With ~$4.1B of net debt against a ~$1.6B equity value, small changes in revenue or margins move the equity a lot in either direction.

The company is bigger and older than its 2020 listing suggests. Its roots go back to SYNNEX's 2004 purchase of BSA Sales, and it took the Concentrix name in 2006. The 2018 acquisition of Convergys made it a top-tier contact-center operator, and after the spin-off it kept buying: PK in December 2021, ServiceSource in July 2022, Webhelp in September 2023, SAI Digital in September 2025 and CastleHill, a governance, risk and compliance firm, in September 2026 (terms undisclosed). Webhelp's owners were paid with 14.9 million Concentrix shares, €500 million in cash and a €700 million two-year note, which is why Groupe Bruxelles Lambert (GBL) affiliates are the largest shareholder, at about 14.2% as of January 2026. Headquarters is in Newark, California, and Chris Caldwell is CEO, with Andre Valentine as CFO.

At the end of fiscal 2025 (November 30, 2025) Concentrix had about 455,000 staff in 74 countries and roughly 483 locations: about 240,000 in Asia-Pacific, 130,000 in EMEA and 85,000 in the Americas. It serves more than 2,000 clients, including over 160 of the Fortune Global 500. The five largest clients made up about 19% of fiscal 2025 revenue, and management cites 98% client retention. Around 89% of revenue came from operations outside the US, while about 54% was priced in US dollars, so currency moves affect both revenue and the cost of delivery.

The core risk is that generative AI lets clients handle more customer contacts themselves or through AI-native vendors, shrinking the volume of paid human support faster than Concentrix can replace it with software revenue. Revenue guidance implies a 3% to 5% decline in Q4, and offshore mix shifts are expected to weigh on revenue through fiscal 2027. Leverage is meaningful at ~$4.1B of net debt, so a prolonged revenue decline would pressure both the dividend and refinancing. Several law firms announced investigations after the June 2026 guidance cut, and the ~$1.05B goodwill impairment shows how far expectations for the Webhelp acquisition have fallen. Currency swings also matter, since most delivery and a large share of revenue sit outside the US. The Q3 write-down was the second in a year: Q4 fiscal 2025 carried a $1.52 billion goodwill impairment, also tied to the share price. Client concentration adds its own exposure, since the top five clients produced about 19% of fiscal 2025 revenue and two hyperscalers are already reducing volumes. Management has given no formal fiscal 2027 guidance and has said Q4 2026 and the first half of 2027 will feel the weight of faster AI automation, so the expected return to growth rests on second-half momentum and possible industry consolidation.

4 analysts publish price targets on CNXC, averaging $33.50 against a $24.91 price as of October 2026, or +34.5%. The published targets run from $29.00 to $45.00, a moderate spread, and the ratings split 3 buy, 1 hold, 0 sell. Over the last six months there have been 0 raises and 4 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CNXC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Concentrix Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Selling AI into the installed base. Concentrix's iX Suite (agent assist and automation tools) had 61 live deployments covering 30,000+ advisers as of Q3 2026, and AI-involved new logo sales grew 63% quarter over quarter. The most optimistic published target, $45.00, assumes this works close to its best case.

The case against. The core risk is that generative AI lets clients handle more customer contacts themselves or through AI-native vendors, shrinking the volume of paid human support faster than Concentrix can replace it with software revenue. The most pessimistic target, $29.00, is roughly what CNXC is worth if this bites instead.

Read the full bull and bear case on CNXC, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Concentrix Corporation's investor relations page or your broker.

• Revenue (TTM): ~$9.9B
• Fiscal 2026 revenue guidance: ~$9.83B to $9.88B
• Non-GAAP EPS (FY2026 guidance): ~$10.97 to $11.09
• Market cap: ~$1.6B (share price ~$26)
• Net debt: ~$4.1B
• Dividend yield: ~5.6% ($1.48 annualized)

On non-GAAP numbers CNXC trades at roughly 2.4x fiscal 2026 earnings and near 2.5x adjusted free cash flow, a valuation that prices in a sustained decline rather than stability. GAAP results show a net loss because of the ~$1.05B Q3 goodwill impairment, which is non-cash but tied directly to the lower stock price. Including debt, enterprise value is roughly $5.7B, or about 4x annualized non-GAAP operating income. For comparison, fiscal 2025 revenue was $9.83B (+2.2%), operating cash flow was $807M and adjusted free cash flow was $626M, so the 2026 cash guidance is roughly flat on a year earlier despite lower revenue. Management has said it expects fiscal 2027 adjusted free cash flow to be higher again, helped by lower restructuring costs, cash interest and capital spending. In June 2026 it had cut full-year non-GAAP EPS guidance to $10.83 to $11.18 from $11.48 to $12.07 and flagged about $175M of restructuring charges.

Other names that sit close to CNXC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CNXC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CNXC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CNXC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

CNXC is a deep-value, high-debt bet that Concentrix can sell AI to its own clients faster than AI takes away the human support work it is paid for.

Whether CNXC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CNXC a buy or a sell?, and where the stock could go from here in the CNXC stock forecast.

For income investors, whether CNXC pays a dividend and how the payout looks is covered in does CNXC pay a dividend? And to weigh CNXC against a peer, read the full side-by-side comparisons: CNXC vs CX and CNXC vs ACN.